- Open Access
The behavioural phenotype of SATB2-associated syndrome: a within-group and cross-syndrome analysis
Journal of Neurodevelopmental Disorders volume 14, Article number: 25 (2022)
SATB2-associated syndrome (SAS) is a multisystem neurodevelopmental disorder characterised by intellectual disability, speech delay, and craniofacial anomalies. Although the clinical presentation of SAS is well-delineated, behaviours associated with SAS are less well-defined. Given the varied social profile reported in SAS of a ‘jovial’ predisposition and autistic behaviours, there may be phenotypic overlap with both Angelman syndrome (AS) and non-syndromal autism. This study aimed to describe behaviours in SAS in relation to chronological age and level of ability and contrast aspects of the behavioural phenotype with AS and non-syndromal autism.
Informant report questionnaire measures of behaviour, emotion, and autism characteristics were completed for 81 individuals with SAS (aged 1–36 years; 43 male). Within-group associations were analysed, and categorical data were compared between pre-school (1–5 years), school-age (6–15 years), and adolescent and adult SAS sub-groups (16 years and over). Cross-syndrome subscale and item-level analyses were conducted for 63 individuals with SAS (aged 1–27 years; 31 male), who were matched according to age and level of ability to 63 individuals with AS (aged 2–25 years; 32 male) and 63 individuals with non-syndromal autism (aged 3–26 years; 53 male).
In SAS, higher rates of overactivity were moderately associated with lower self-help ability, and higher general anxiety scores were reported for males compared with females. Cross-syndrome subscale analyses uncovered several significant differences (p < .01), with comparatively low rates of stereotyped behaviour, overactivity, insistence on sameness and positive affect, and comparatively greater interest and pleasure and compulsive behaviour in individuals with SAS. Item-level analyses revealed a distinct profile of repetitive and autistic behaviours.
Developmental analysis was based on a cross-sectional rather than a longitudinal research design, the contribution of pain and sleep to behaviour was not explored, and molecular genetic testing to determine genotype–phenotype behavioural relationships was not possible.
This study highlights the importance of behavioural comparisons to well-delineated groups and the utility of fine-grained item-level analyses to elucidate aspects of behaviour that might be syndrome related or shared across neurodevelopmental disorders. Future research is needed to further describe the distinctive repetitive and autistic behavioural phenotype in SAS.
Functional haploinsufficiency of the special AT-rich sequence-binding protein 2 (SATB2) gene located on chromosome 2q33.1 [1,2,3] is associated with craniofacial defects, most notably cleft palate [4, 5]. SATB2 gene variants are associated with a number of co-occurring manifestations (OMIM #612313), resulting in designation of a single clinically recognised syndrome  of SATB2-associated syndrome (SAS). SAS has an estimated frequency in undiagnosed developmental delay or intellectual disability of ~ .24 to .30% [6, 7]. Given the role of the SATB2 gene in neurodevelopment, the presentation of epileptiform discharges and diagnosis of seizures is particularly important, with an estimated prevalence of 93% and 42% respectively in SAS . Regardless of variant (missense = 31%, nonsense = 24%, frameshift = 20%, intragenic deletion = 14% ) a consistent clinical phenotype is evident . A diagnostic acronym has been adopted to enable the evaluation and surveillance of SAS : severe speech anomalies (S); abnormalities of the palate (A); teeth anomalies (T); atypical behaviour, bone anomalies, and/or brain defects (B); and age of onset before 2 years (2).
Developmental delay and intellectual disability with delayed language acquisition are considered the hallmark universal characteristics of SAS . In a recent clinical review of 121 school-age children and adults with SAS, 84% spoke fewer than ten words, and 42% evidenced completely absent speech . Spoken language is not always a target for intervention in SAS and alternative means of expressive communication are possible with symbolic modalities such as sign language and picture communication systems , and therefore, communicative abilities of non-verbal individuals should not be underestimated. As such, a consideration of both receptive (the ability to comprehend and understand language) and expressive communication abilities (the ability to communicate thoughts, feelings, and needs with others) is important, as evidence in intellectual disability populations suggests stronger receptive communication abilities relative to expressive communication. Although there is some indication of relative strengths in receptive and non-verbal communication compared with spoken language in SAS , evidence is mixed when standardised assessments of communication are used. Direct assessment of communication profiles in 61 individuals with SAS elucidated both receptive and expressive language deficits , with only marginal gains in receptive vocabulary raw scores measured using the Test for Auditory Comprehension of Language–Fourth Edition  observed over time.
Although ‘behavioural issues’ (reported in 55% of individuals ) are one of the core diagnostic features of SAS, this broad categorisation is highly generalised and may obscure identification of specific behaviours. Based on clinical observation, autistic behaviours are described alongside a happy jovial disposition [7, 9, 11, 15]. Clinical case reports make reference to a ‘friendly’ disposition , hand stereotypies , repetitive interests, ‘inappropriate’ social behaviours (e.g. frequent touching and hugging, spontaneous bouts of laughter) and ‘autistic-like’ features . Evidently, the description of behavioural characteristics in SAS varies markedly between individuals, and it is not clear how frequently these specific behavioural topographies occur in the larger SAS population.
Given the distinctive social profile evident in SAS, a differential diagnosis of Angelman syndrome (AS) is often considered in early infancy [4, 15]. AS is a clinically recognised syndrome characterised by frequent laughing and smiling, a happy demeanour, and absent speech [19, 20], and often accompanied by high rates of physical aggression  and clinically diagnosed autism . Recently, whole exome sequencing analysis has identified the SATB2 gene as one of ten genes associated with an ‘AS-like’ phenotype in individuals with clinical features of AS of unknown genetic cause . This highlights the clinical need to further delineate similarities and differences between these two syndromes in the present study.
Despite the significant phenotypic overlap with AS, SAS research to date has not utilised behavioural comparisons with analogous neurodevelopmental disorders to document the behavioural phenotype that characterises SAS. Similarly, autistic behaviours in SAS have not been comprehensively explored compared with a non-syndromal autism group. Autism is disproportionately diagnosed in males compared with females by a ratio of ~ 3:1  that may reflect diagnostic overshadowing and sex- and gender-related differences in autism presentation in females . It is important to note that such sex- and gender-related differences have not been reported in the current SAS literature . Such group contrasts would be of clinical value to families and professionals, since qualitative differences in autism presentation exist between genetic syndrome groups associated with intellectual disability and autism [26, 27]. Evidently, there is a significant gap in knowledge about the SAS behavioural phenotype and a need to elucidate behavioural specificity in SAS using group-level cross-syndrome contrasts.
While clinical observations of aggressive behaviour (31%), hyperactivity (23%), agitation (> 45%), obsessive tendencies (~ 25%), sensory issues (~ 10%), and ‘difficult’ behaviour (11%) have been reported in SAS [7,8,9,10], specific behavioural topographies have rarely been explored. To date, only one study with children aged 2–16 years  has evaluated behaviour and emotion in SAS via use of a standardised measure—the Strengths and Difficulties Questionnaire (SDQ [29, 30]). Compared with normative data, children with SAS obtained higher SDQ scores for emotional problems, conduct problems, hyperactivity, and peer relationships and lower scores for prosocial behaviours. The SDQ impact score (as a measure of caregiver burden) was significantly higher in the SAS group compared with the normative group, with overall distress increasing with chronological age. However, the psychometric properties of the SDQ have not been established for populations with severe intellectual disability, and this study did not explore the behavioural profile or associated caregiver impact in adolescents or adults with SAS. Although there is some indication of change in behaviour over time based on clinical observation (e.g. tantrums, meltdowns, and aggressive outbursts in childhood with more physical acts of aggression towards others emerging in adolescence and adulthood ), these changes have never been explored using validated and standardised measures of specific behaviours.
To further delineate the behavioural phenotype of SAS, it is important to: (1) describe specific behaviours in association with age and take into account aspects relating to caregiver well-being, (2) utilise standardised measures with established psychometric properties and use in neurodevelopmental disorders associated with intellectual disability across all age groups, and (3) draw comparisons to contrast groups to characterise the specificity, nature, and severity of behaviours in SAS. In the largest standardised study of behaviours in SAS to date, this study aimed to:
Compare the profiles of specific topographies of behaviour and caregiver well-being scores between SAS developmental sub-groups: pre-school children, school-age children, and adolescents and adults with SAS, and explore associations between SAS participant characteristics and aspects relating to behaviour, autism, emotion, and caregiver well-being (within-group analysis).
Refine description of the behavioural phenotype in SAS through application of standardised measures appropriate for use in those with intellectual disability, comparing profiles in SAS to ability- and age-matched contrast groups at both subscale and item-level (AS and non-syndromal autism; cross-syndrome analysis).
Families caring for individuals with SAS were recruited in 2018–2019 via mailing list emails and social media research advertisements shared via closed groups affiliated with two support group organisations: the SATB2 Gene Trust UK and the international SATB2 Gene Foundation (USA). Families were included if they were the parent/caregiver of an individual with SAS aged 1 year and over diagnosed by a paediatrician, clinical geneticist, general practitioner, or neurologist and if the caregiver had proficient English language ability. Caregivers were invited to share genetic confirmation letters (where such a record of genetic information was available and families consented to genetic confirmation sharing).
The AS and non-syndromal autism groups were derived from a pre-existing dataset of participants held by the Cerebra Centre for Neurodevelopmental Disorders, University of Birmingham. These groups were originally recruited via the Angelman Syndrome Support Education and Research Trust and the National Autistic Society. Ethical approval was granted by Coventry Research Ethics Committee. Participants had received a diagnosis of AS or autism from a paediatrician, clinical geneticist, general practitioner or neurologist. As these data were collected as part of a larger questionnaire study for a historical dataset, genetic confirmation of diagnosis to determine molecular or chromosomal variants within the AS group cannot be reported. AS questionnaire responses were collected from 2003 to 2012, and non-syndromal autism questionnaire data were collected in 2007.
Parents/caregivers of children and adults with SAS completed an online survey created using LimeSurvey 2.00+ software . The online survey included an information sheet, consent forms, and questionnaire measures (see Measures). Additional questionnaire measures were included in the SAS online survey that were not available for the AS and autism datasets. Therefore, cross-syndrome comparisons are not available for all measures included in the within-group SAS–only analysis (see Measures for further information).
Data were excluded from three participants with SAS for whom a genetic diagnosis by a clinical professional was not reported. SAS genetic confirmation letters were available for 33 individuals. Overall, 81 participants with SAS were included in the SAS within-group analysis. To broadly explore age-related differences in SAS, the group was first divided according to three developmental sub-groups: pre-school children (aged 1–5 years), school-age children (aged 6–15 years), and adolescents and adults (aged 16 years and older).
Demographic and health-related information across developmental sub-groups is provided in Table 1. There were no significant differences between SAS developmental sub-groups for demographic characteristics such as gender or verbal ability, or health characteristics such as dental problems or cleft palate. Unsurprisingly, a difference in average self-help score, as measured by the Wessex Behavior Scale  as a proxy measure of level of ability, did approach statistical significance, with self-help score increasing with chronological age.
Participants within each syndrome group (SAS, AS, and autism) were ranked in ascending order. Each participant with SAS was matched to one participant with AS and one participant with non-syndromal autism, first according to self-help score (± 2 points) then chronological age (± 3 years). Following this matching strategy, some participants could not be matched within 2 points or 3 years, and 18 participants were excluded from the cross-syndrome analysis.
It is important to note, that there was a trend towards significance of these 18 excluded participants being older than those included in the cross-syndrome analysis (see Supplementary Materials 1; Additional File 1), but did not differ on any other demographic variables, such as gender or level of ability. Although gender is an important consideration in relation to autism profile, it was not possible to match according to gender in the present study. The existing autism dataset included only 42 females, and therefore, matching between the SAS and non-syndromal autism group would have been severely limited, leading to further participant exclusions (see Limitations for further comments). The included 63 participants were ability- and age-matched to 63 individuals with non-syndromal autism and 63 individuals with AS (see Table 2). There were fewer males with SAS or AS than non-syndromal autism and more mobile participants with SAS and autism than AS. There were also fewer verbal participants with SAS and AS than autism and more verbal participants with SAS than AS.
Full descriptions of the measures used and their psychometric properties are presented in Table 3 [32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47]. Please note that for the majority of measures, higher scores indicate greater degree of difficulty, with the exception of the Mood, Interest, and Pleasure Questionnaire-Short Form (MIPQ-S) where higher scores are indicative of positive affect and increased interest and pleasure.
Data were analysed using Statistical Package for Social Sciences (SPSS), version 27. Within-group analyses broadly compared categorical data and cut-off scores between SAS developmental sub-groups using Chi-square analyses. Associations were also explored in the SAS group between participant characteristics and questionnaire subscales using Spearman rank correlation coefficients (two-tailed, p < .01) for continuous data and eta values for nominal by interval data (values closer to 1 indicating a higher degree of association). Across analyses, normality and homogeneity of variance were assessed via Shapiro–Wilk and Levene’s tests respectively; distributions were deemed to violate skewness and kurtosis when value/standard error statistics were greater than 1 SD (1.96).
In the cross-syndrome analysis, Chi-square tests were employed to compare categorical data between SAS, AS, and autism, and parametric one-way analyses of variance or nonparametric Kruskal–Wallis tests were conducted to compare continuous data between neurodevelopmental groups. Social Communication Questionnaire (SCQ) item-level analyses were calculated for 55 participants with SAS, 58 participants with AS, and 60 participants with autism (aged 4 years and over), and Repetitive Behaviour Questionnaire (RBQ) item-level analyses for four verbal items (questions, echolalia, attachment people, and conversation) were not calculated for the AS group. Non-verbal participants were not included in The Activity Questionnaire (TAQ) impulsive speech, RBQ restricted preferences, or RBQ repetitive speech developmental sub-group and cross-syndrome comparisons, as these subscales are not suitable for individuals with limited verbal ability.
Significant group differences were interrogated with the appropriate categorical (one-way Chi-square test), parametric (independent t test), or nonparametric (Mann–Whitney U test) post hoc analyses. Given the moderate sample sizes, exact rather than asymptotic significance tests were employed. To minimise the likelihood of type 1 errors, significant group difference alpha values were set at p < .01 to account for multiple-group comparisons. To prevent overreliance on statistical significance in the interpretation of the data, non-significant group differences were explored using Bayesian analyses to determine the degree of ‘commonality’ between groups (as outlined by Surtees et al. ). Such analyses are of clinical importance when considering similarity of the SAS phenotype to well-delineated neurodevelopmental groups. A Bayes Factor (BF01) is used to quantify support for the null hypothesis (groups do not differ) over the alternative hypothesis (groups significantly differ). Bayesian approaches do not rely on arbitrary cut-offs to establish ‘significance of commonality’, but in line with guidelines proposed by Jeffreys , a BF01 ≥ 3 provides ‘moderate and greater’ evidence in favour of the null hypothesis.
Post hoc group differences presented within the main text predominantly consider SAS–AS and SAS–autism comparisons in line with the study aims outlined. However, post hoc cross-syndrome analysis on AS–autism comparisons at both subscale and item-level is provided in the supplementary materials (see Supplementary Material 2 and 3; Additional File 1). Full statistical analysis of post hoc group differences at item level for the SCQ (SAS–AS, SAS–autism, AS–autism) are also provided within this supplementary information.
Within-group SAS–only analysis
To determine the clinical utility of dividing the SAS group according to three developmental sub-groups, categorical data and cut-off scores were compared between pre-school children, school-age children, and adolescents and adults as presented in Table 4. There were no significant differences between developmental sub-groups for any measures of behavioural, autism, or emotional characteristics or on the Hospital Anxiety and Depression Scale (HADS) measure of caregiver well-being. The number of caregivers reaching clinical cut-off scores for anxiety was high across the pre-school children (76.7%), school-age children (62.9%), and adolescents and adults sub-groups (62.5%). The presence of self-injury and aggression was markedly high across all developmental sub-groups, as were the number of individuals meeting SCQ cut-off scores ≥ 15 (pre-school children: 35.0%; school-age children: 54.3%; adolescents and adults: 68.8%) as a measure of autism spectrum disorder characteristics. It is important to note however that differences in reported presence of property destruction did approach statistical significance, with a trend towards increasing prevalence with chronological age.
Given that the adolescents and adults SAS sub-group was not sufficiently sized to explore age-related differences at a group level, exploratory correlational analyses and eta values were reported to determine significant associations between SAS participant characteristics and questionnaire subscale scores (see Table 5). Chronological age and level of ability (continuous variables) and gender and seizure presentation (nominal variables) were selected as participant characteristics to explore in association with behaviour, autism, emotion, and caregiver well-being subscale scores, given their established or anticipated relevance to the SAS behavioural phenotype.
Overall, few significant associations were observed between participant characteristics and behavioural questionnaire subscale scores. A moderate negative association was found between overactivity subscale scores and level of ability (rs = − .423, p < .001) and an association was found between gender and Anxiety, Depression, and Mood Scale (ADAMS) general anxiety subscale scores (η = .478). Given that eta value direction of association or statistical significance cannot be inferred, interpretation was supplemented using a post hoc group analysis. ADAMS general anxiety subscale scores were significantly higher in males compared with those in females (U(1) = 361.00, Z = -4.331, p < .001, BF01 = .000).
To contrast the profile of behaviours evident in SAS with well-delineated AS and autism phenotypes, categorical data, subscale average scores, and cut-off scores for the SAS group as a whole were compared with ability- and age-matched AS and non-syndromal autism groups.
As shown in Fig. 1a–c, there were no significant differences between neurodevelopmental groups for: prevalence of self-injury, prevalence of specific topographies of self-injury, mean self-injury severity scores, or presence of physical aggression (prevalence of aggression was comparatively high across all groups). There were, however, significant differences relating to presence of property destruction, with higher rates observed in AS (84.7%). Differences were significant for both SAS–AS (46.8%; χ2(1) = 19.234, p < .001) and AS–autism group comparisons (59.0%; χ2(1) = 9.778, p = .002).
TAQ responses (see Fig. 1d) indicated no significant differences in impulsivity subscale scores between neurodevelopmental groups (SAS–aut: U(1) = 1882.00, Z = − .502, p = .618, BF01 = 7.176; SAS–AS: U(1) = 1794.00, Z = -.788, p = .433, BF01 = 5.195). However, scores on the overactivity subscale were comparatively lower in individuals with SAS than individuals with AS (U(1) = 1396.00, Z = -2.752, p = .006, BF01 = .138) and individuals with autism (U(1) = 1352.00, Z = -3.088, p = .002, BF01 = .076), despite decreased mobility in the AS group. The SAS group also evidenced a lower median impulsive speech subscale score than individuals with autism (U(1) = 207.50, Z = − 3.543, p < .001, BF01 = .011).
Both SAS and AS groups obtained higher mood (SAS: U(1) = 1293.00, Z = − 3.394, p = .001, BF01 = .289; AS: U(1) = 885.50, Z = − 5.307, p < .001, BF01 = .000) and interest and pleasure MIPQ-S subscale scores (SAS: U(1) = 985.00, Z = − 4.887, p < .001, BF01 = .000; AS: U(1) = 865.00, Z = − 5.835, p < .001, BF01 = .000) than individuals with autism (see Fig. 2). Median subscale scores were convergent for SAS and AS, and highly convergent in relation to interest and pleasure when BF01 values were scrutinised (mood: U(1) = 1570.00, Z = − 1.912, p = .056, BF01 = .661; interest and pleasure: U(1) = 1887.50, Z = − .325, p = .747, BF01 = 5.001). It is important to note, not all individuals with SAS evidenced comparatively high interest and pleasure scores, as eight individuals with SAS obtained scores ≤ 10 (see Fig. 2).
Across all SCQ subscales (see Fig. 3a), the SAS group evidenced lower subscale scores than the autism group (reciprocal social interaction: U(1) = 459.50, Z = − 6.613, p < .001, BF01 = .000; communication: U(1) = 384.00, Z = − 7.059, p < .001, BF01 = .000; restrictive, repetitive, and stereotyped behaviours: U(1) = 862.00, Z = − 4.460, p < .001, BF01 = .000). There were no significant differences between SAS and AS across SCQ subscale scores (reciprocal social interaction: U(1) = 1416.50, Z = − .883, p = .380, BF01 = 5.239; communication: U(1) = 1425.50, Z = − .833, p = .407, BF01 = .236; restrictive, repetitive, and stereotyped behaviours: U(1) = 1420.00, Z = 1.016, p = .312, BF01 = 3.821).
Fewer individuals with SAS (≥ 15: 52.7%; ≥ 22: 17.8%) met clinical cut-off scores on the SCQ than individuals with autism (≥ 15 (100.0%): χ2(1) = 36.131, p < .001; ≥ 22 (67.1%): χ2(1) = 40.505, p < .001). There were however no significant differences between SAS and AS in relation to the number of individuals meeting SCQ clinical cut-off scores (≥ 15 (54.4%): χ2(1) = .031, p = 1.000; ≥ 22 (15.1%): χ2(1) = .313, p = .648). Post hoc AS–autism comparisons are presented in Additional File 1.
On the verbal subscales of the RBQ (see Fig. 3b), there were no significant differences between SAS and autism in relation to restricted preferences (U(1) = 378.50, Z = − 1.144, p = .256, BF01 = 2.788) or repetitive speech (U(1) = 345.50, Z = − 1.606, p = .109, BF01 = 1.312). In relation to stereotyped behaviour, individuals with SAS obtained lower average scores than individuals with autism (U(1) = 1323.00, Z = − 3.255, p = .001, BF01 = .028).
Both SAS and autism groups evidenced higher compulsive behaviour (SAS: U(1) = 937.00, Z = − 5.211, p < .001, BF01 = .000; autism: U(1) = 731.00, Z = − 6.114, p < .001, BF01 = .000) and insistence on sameness subscale scores (SAS: U(1) = 999.00, Z = − 4.955, p < .001, BF01 = .000; autism: U(1) = 695.50, Z = − 6.208, p < .001, BF01 = .000) than the AS group. Median subscale scores were however more convergent for SAS and autism in relation to compulsive behaviour (U(1) = 1784.50, Z = − .835, p = .406, BF01 = 5.031) and insistence on sameness (U(1) = 1494.50, Z = − 2.026, p = .043, BF01 = 1.109).
Overall, cross-syndrome autism characteristics as measured by the SCQ and RBQ at subscale level revealed significant differences between SAS and autism, which were convergent for SAS and AS (SCQ: reciprocal social interaction; communication; restrictive, repetitive and stereotyped behaviours; RBQ: stereotyped behaviour) and significant differences between SAS and AS, which were convergent for SAS and autism (RBQ: compulsive behaviour, insistence on sameness).
Item-level cross-syndrome analysis
To elucidate whether fine-grained similarities and differences in autism profile existed between neurodevelopmental groups, SCQ and RBQ item-level analyses were conducted.
SCQ item-level analysis
SCQ item-level analyses are presented in Table 6. Within the SCQ reciprocal social interaction domain, individuals with SAS were more likely to be reported as evidencing impairment on nine items compared with individuals with AS (inappropriate facial expressions, eye gaze, social smiling, showing and directing attention, seeking to share enjoyment, quality of social overtures, range of facial expressions, interest in other children, response to other children’s approaches). Across four items (inappropriate facial expressions, showing and directing attention, seeking to share enjoyment, quality of social overtures), individuals with SAS were more likely to be reported as evidencing impairment compared with individuals with autism. On three items (range of facial expressions, interest in other children, response to other children’s approaches), there were no significant differences between SAS and autism. Individuals with SAS were however less likely to evidence impairment on two items (imaginative play with peers, group play) compared with individuals with AS and autism.
Within the communication domain, there were no significant differences between the three groups in relation to pointing to express interest, gestures and head shaking to mean no, and no significant differences between SAS and autism on six verbal items (conversation, stereotyped utterances, inappropriate questions, pronoun reversal, neologisms, social chat). However, significantly fewer individuals with SAS were reported to evidence impairment on four items on autism (imitation, nodding to mean yes, imitative social play, imaginative play) compared with individuals with autism.
Within the restrictive, repetitive, and stereotyped behaviour domain, more individuals with SAS and autism evidenced compulsions and rituals than individuals with AS. Across all three groups, there were no significant differences relating to repetitive use of objects. Across three items however (unusual sensory interests, head and finger mannerisms, complex body mannerisms), fewer individuals with SAS were noted to evidence difficulty than individuals with autism. There were no differences between groups relating to self-injury, but significantly more individuals with SAS compared with AS evidenced difficulty with unusual attachment to objects and attention to voice.
RBQ item-level analysis
RBQ item-level radar graphs for each neurodevelopmental group are presented in Fig. 4. Mean item scores are presented to provide visual representation; however, nonparametric Kruskal–Wallis test statistics and post hoc Mann–Whitney U tests were conducted. Compared with the AS group, the SAS group obtained significantly higher median item scores on eight items: five items within the compulsive behaviour subscale (tidying: U(1) = 1501.50, Z = − 2.933, p = .003; organising: U(1) = 1425.50, Z = − 3.860, p < .001; rituals: U(1) = 1416.00, Z = − 3.687, p < .001; lining: U(1) = 1028.00, Z = − 5.707, p < .001; completing: U(1) = 1233.00, Z = − 4.811, p < .001), both items within the insistence on sameness subscale (routine: U(1) = 1158.00, Z = − 4.164, p < .001 and just right: U(1) = 1220.50, Z = − 4.879, p < .001), and one item within the restricted preferences subscale (attachment objects: U(1) = 1225.50, Z = − 3.960, p < .001).
Compared with autism, the SAS group obtained significantly lower median item scores on three items: two items within the stereotyped behaviour subscale (body stereotypy: U(1) = 1411.00, Z = − 2.936, p = .003; hand stereotypy: U(1) = 1371.00, Z = − 3.177, p = .001), and one item within the repetitive speech subscale (echolalia: U(1) = 217.00, Z = − 3.537, p < .001).
This study represents the largest sample of SAS behavioural data using standardised measures validated for individuals with intellectual disability, and is the first SAS study to adopt a cross-syndrome comparative approach to further delineate the profile of behaviours in this group. In summary, there were no significant developmental sub-group differences in cut-off scores or categorical questionnaire scores between pre-school children, school-age children, or adolescents and adults with SAS. Significant associations were found between higher rates of overactivity and lower self-help ability, and gender and general anxiety, with higher general anxiety scores reported for males with SAS compared with females. Cross-syndrome analysis revealed several distinct differences between SAS, AS, and non-syndromal autism groups, with SAS evidencing a behaviour profile characterised by comparatively low rates of property destruction, overactivity, impulsive speech, stereotyped behaviour, insistence on sameness, in contrast to positive affect and higher rates of interest and pleasure and compulsive behaviour. Although the SAS group obtained lower SCQ subscale scores than individuals with non-syndromal autism, fine-grained item-level analysis of both the SCQ and RBQ highlighted areas of significant difference, pinpointing a profile of repetitive behaviours, communication, and reciprocity with others that is distinct from both AS and autism.
Behavioural characteristics: self-injury and aggression
In relation to the presentation of behaviours, 43% of children and adults with SAS evidenced self-injury, comparable to rates of self-injury reported in the wider non-syndromal autism literature (42% ). Cross-syndrome analysis in the present study did not elucidate any syndrome-related differences in relation to self-injury. SAS rates reported here are comparatively lower than rates of self-injury reported in Cri du Chat syndrome (77%), Cornelia de Lange syndrome (70%), and Smith-Magenis syndrome (93% ). Some may argue self-injury may not be a ‘hallmark’ behavioural characteristic of SAS when compared with Smith-Magenis syndrome for example . However, a prevalence rate of 43% is still markedly high when compared with the general intellectual disability literature (12% ), and as such, the potential correlates of risk that may differentiate those with SAS who present with self-injury from those that do not warrant further investigation. Physical aggression was markedly high in SAS (77%) when compared with both the general intellectual disability literature (2–24% [53,54,55]) and rates of 20–31% that have previously been reported in the SAS literature [9, 10]. This may reflect methodological differences in data collection (informant report or clinical observation) and whether previous studies have utilised operationalised definitions of ‘aggressive’ behaviour (for example, taking into account differences between verbal, physical, and sexual aggression). In this study, a distinction was made between physical aggression (aggression directed towards others) and property destruction (aggression directed towards the environment), with lower rates of property destruction in SAS (47%) and autism (59%) compared with AS (85%).
Behavioural characteristics: overactivity and impulsivity
At subscale level, individuals with SAS were reported by caregivers to evidence lower overactivity scores than individuals with AS or non-syndromal autism. Although overactivity has previously been reported in the SAS literature as characteristic of the behavioural phenotype , adopting a cross-syndrome comparison approach with AS, a well-delineated syndrome group with consistently high rates of overactivity [56, 57], has enabled us to weigh comparative overactivity ‘risk’ in SAS. When weighted against AS, overactivity may not be a defining characteristic of SAS. However, further examination of the data found relative to a maximum impulsivity subscale score of 24, moderately high median scores were reported across neurodevelopmental groups (SAS = 19, AS = 18.5, autism = 19), and there was notable variability in both overactivity and impulsivity TAQ subscale scores within the overall SAS group (n = 81; overactivity = 0–36, impulsivity = 3–24). Evidently, some individuals with SAS obtained high overactivity and impulsivity scores, but this is not meaningfully captured via group-level analyses.
Within-group analysis of the SAS cohort revealed a moderate association between higher rates of overactivity and lower self-help abilities. A similar relationship is reported in fragile X syndrome (FXS), a syndrome in which overactivity and impulsivity are particularly pronounced and described as a core behavioural phenotype . In FXS, younger mental age is associated with increased likelihood of meeting diagnostic criteria for attention deficit hyperactivity disorder (ADHD) . Future research in SAS should explore FXS-SAS cross-syndrome comparisons and item-level analyses of overactivity and impulsivity. Using FXS research as a theoretical model, SAS research should also consider potential associations with executive functioning deficits and the clinical utility of existing ADHD diagnostic criteria . Furthermore, in syndrome groups such as FXS , as well as the non-syndromal autism literature , overactivity and impulsivity are identified as predictors of both the presence and persistence of self-injury and aggression. As such, the SAS literature would benefit from longitudinal research to delineate whether overactivity or impulsivity predict other severe forms of behaviours that challenge.
It is reassuring to note that no negative associations between mood or interest and pleasure subscale scores and chronological age were found, given that decline in levels of affect with age have been reported in other genetic syndrome groups [63, 64]. There are several challenges when exploring the mental health profiles of individuals with intellectual disability and autism, particularly the appropriateness of clinical measures and diagnostic criteria when individuals do not communicate using spoken language . Although the present findings align with previous SAS literature regarding positive mood and affect [7, 11], and a highly convergent interest and pleasure profile with AS, a syndrome group where positive mood and affect are well-delineated [19, 20], eight individuals with SAS obtained markedly low interest and pleasure subscale scores. Given that there is an established relationship between low mood and the presentation of health problems in individuals with genetic syndromes associated with intellectual disability , professionals and caregivers should monitor whether any changes in health correlate with a noticeable change in mood. If changes are observed, it cannot be ruled out that pain may underlie some forms of behaviour . Similarly to overactivity and impulsivity, low mood is a significant risk marker for self-injury [21, 62]. Future SAS behavioural phenotype research should therefore prioritise exploring the contribution of factors relating to an individual’s quality of life (e.g. untreated pain, health, affect, anxiety, and depression).
Such factors are difficult to measure in individuals who speak few or no words. Although the ADAMS was used in the present study as a measure of depression and anxiety (with good psychometric properties for validation in children and adults with intellectual disability; Table 3), several of the depressed mood items relate to sleep (e.g. easily fatigued) and several general anxiety items are also non-verbal indicators of pain (e.g. motor tension). The moderate association between gender and ADAMS general anxiety subscale scores, with higher scores evident in males compared with females, contradicts the consistent gender difference of higher prevalence of anxiety disorders in females compared with males reported in the general literature . More research is needed to determine whether this general anxiety gender difference in SAS is replicable and observed across multiple contexts and whether the ADAMS is an appropriate measure in SAS. It is difficult to determine whether high ADAMS subscale scores accurately depicted depressed mood and anxiety, or were confounded by other biological characteristics of SAS that were not measured in the present study. Namely, sleep disorders that are particularly prevalent in young children , and painful dental and craniofacial abnormalities frequently reported in SAS . Future behavioural research would benefit from the inclusion of sleep and pain measures that are validated in minimally verbal intellectual disability populations that do not violate multicollinearity assumptions with measures of depression and anxiety.
Several autism characteristics were reported across all SAS developmental sub-groups at relatively high rates. Overall, 46% of children, adolescents, and adults with SAS met cut-off scores for autism spectrum disorder according to the SCQ. This is comparatively high when weighted against the prevalence of autism in other syndrome groups associated with autism and intellectual disability . It is possible that the SCQ as a screening tool overestimates the diagnostic prevalence of autism characteristics in genetic syndrome groups , and as such further research is needed using ‘gold standard’ diagnostic measures (e.g. the Autism Diagnostic Observation Schedule ). However, there are clear clinical implications in adopting an SCQ item-level analysis approach as evidenced in other genetic syndrome groups , and a novel contribution to the literature in elucidating where the autism profile in SAS may deviate from the profile seen in non-syndromal autism. Compared with the non-syndromal autism group, individuals with SAS were more likely to evidence impairment on items relating to inappropriate facial expressions, showing and directing attention, seeking to share enjoyment, quality of social overtures, and less likely to evidence impairment on a number of play-focused and communicative items (imaginative play with peers, group play, imitation, imitative social play, imaginative play, and nodding to mean yes). From a clinical perspective, there are two key aspects to consider: (1) the effectiveness of targeted interventions based on the syndrome-related profile of autism characteristics in SAS; for example, the Joint Attention Symbolic Play Engagement and Regulation programme  could evidence particular promise in SAS, given that existing SAS play-based skills could be utilised to target relative areas of difficulty, namely the use of non-verbal social cues and joint attention skills. (2) Whether deficits in reciprocal social interaction are generalised or person specific; future research should aim to clarify whether non-verbal social difficulties in SAS are context specific, perhaps more closely aligning with a social anxiety profile or absence of social motivation as reported in other syndrome groups , or whether these difficulties are independent of social context, and do in fact align with a neurodevelopmental diagnosis of autism.
RBQ and SCQ item-level analyses pinpointed a clear discord between low-level stereotyped behaviour and high-level ritualistic and compulsive behaviours in SAS. Although stereotyped behaviours have been previously described in SAS case reports , this is the first cohort study to specifically delineate a ritualistic and compulsive repetitive behaviour profile in SAS. The wider non-syndromal autism literature highlights a distinction between lower-order and higher-order repetitive behaviours in relation to level of ability (e.g. stereotyped behaviours index low cognitive functioning and compulsive behaviours index high cognitive functioning ); however, the current SAS findings do not provide evidence of this distinction. The SAS group evidenced lower rates of hand and body stereotypies compared to non-syndromal autism, and higher rates of compulsive behaviours (e.g. tidying, organising, lining) compared with AS. These findings align with anecdotal reports that reference the need for objects to have their specific place and family members to adhere to fixed routines. Whether such compulsive behaviours are extrinsically mediated by social and environmental factors, or intrinsically driven by anxiety or cognitive factors such as executive functioning deficits, remains unclear. To inform behavioural intervention , functional analysis methodology would elucidate the extent to which intrinsic, extrinsic, and even anxiety-related factors underpin individual repetitive behaviour profiles in SAS.
Although this study has detailed several novel findings, utilising informant-report measures with enhanced specificity to explore behaviours in children and adults with SAS beyond subscale level, there are several methodological limitations to outline. It is important to emphasise the under-diagnosis of this recently recognised syndrome [7, 10]. This is the largest study of behavioural characteristics in SAS and makes a considerable clinical contribution to the literature; however, the skewed younger distribution of infants and young children presents an obvious threat to validity. Furthermore, exploratory genetic syndrome research with small samples is restricted by the effects of multiplicity and the family-wise error rate when performing multiple tests. Although a more conservative alpha value was employed, and a Bayesian analysis ‘weighted probability’ approach was adopted to supplement a strictly ‘frequentist’ approach , the false discovery rate of type 1 errors requires cautious consideration.
In favour of recruiting a representative sample to ensure external validity, an online international method of data collection was employed, relying exclusively on informant -report questionnaire measures. For brevity, the SCQ was used as a screening measure of autism and the Wessex Behavior Scale as a proxy measure of self-help abilities. Utilising a proxy measure undoubtedly oversimplified the developmental and intellectual profile of the SAS group, and the capacity of this study to adopt a more rigorous matching strategy based on level of ability. As such, the non-syndromal autism group may have lower adaptive functioning than reported in the wider autism population [77, 78]. Although the disproportionate male:female distribution evident in our non-syndromal autism group does reflect gender bias observed in the autism community , it is an obvious limitation that autism characteristics in SAS were explored without controlling for gender. Future social and behavioural models in SAS should consider the role of gender as a covariate or control variable.
Furthermore, several assessments were beyond the scope of the present study. As previously discussed, the potential contributions of untreated pain and poor sleep to the behavioural profile in SAS was not explored. Genotype–phenotype correlations were also not analysed within this study. Although participants had a confirmed genetic diagnosis of SAS, molecular genetic testing was not obtained for the majority of individuals. There is a largely consistent clinical phenotype in SAS independent of variant, but it is important to note genotype–phenotype analysis has elucidated some ‘phenotypic variation’ that may also apply to behavioural presentation, particularly in relation to larger contiguous deletions encompassing the SATB2 gene . Language delay and seizure severity (both evident in SAS) are both identified as risk markers for behaviours that challenge in the wider neurodevelopmental literature [81, 82]. In SAS, more individuals with missense variants have absent speech and fewer individuals with nonsense variants have clinical seizures . The present study was unable to account for the prevalence of larger intergenic variant subtypes as an extraneous variable associated with behaviours in SAS.
Few significant associations were observed between participant characteristics and behavioural questionnaire subscale scores in the SAS group, except for a moderate negative correlation between overactivity and level of ability and higher general anxiety subscale scores in males compared with females. Overall, high levels of physical aggression (according to the Challenging Behaviour Questionnaire [CBQ]) and autistic behaviour (according to the SCQ) were reported by caregivers within the SAS cohort. Compared to age- and ability-matched AS and non-syndromal autism groups, the SAS cohort evidenced a comparative profile of positive affect and interest and pleasure as seen in AS, and a comparative profile of compulsive behaviour and insistence on sameness as seen in non-syndromal autism. At item-level, individuals with SAS evidenced a distinct repetitive behaviour profile characterised by low levels of stereotyped behaviours and high levels of compulsive behaviour (e.g. rituals) and insistence on sameness (e.g. attachment to objects). SCQ item-level analysis also revealed a distinct profile of autistic characteristics in SAS that differed from the non-syndromal autism group, with relative strength reported in relation to social behaviours, such as imitative social play and imaginative play, but relative difficulties in non-verbal social interactions, such as social overtures, directing attention and facial expressions. This SCQ item-level analysis approach uncovered variability in the autism profile and specific areas of strength and difficulty in SAS that were not apparent at subscale level. These findings have important clinical implications regarding the appropriateness and utility of existing autism and behavioural interventions in SAS, given the substantial qualitative differences in autism presentation in this syndrome group.
Availability of data and materials
The data that support the findings of this study are not publicly available. Due to the sensitive nature of personal data collected, participants were not asked to provide consent for data sharing as part of their research participation.
Special AT-rich sequence-binding protein 2
Strengths and Difficulties Questionnaire
Gastro-oesophageal Distress Questionnaire
Social Communication Questionnaire
Repetitive Behaviour Questionnaire
Challenging Behaviour Questionnaire
The Activity Questionnaire
Mood, Interest, and Pleasure Questionnaire Short Form
Anxiety, Depression, and Mood Scale
Hospital Anxiety and Depression Scale
Statistical Package for Social Sciences
- BF01 :
Fragile X syndrome
Attention deficit hyperactivity disorder
Britanova O, Akopov S, Lukyanov S, Gruss P, Tarabykin V. Novel transcription factor SATB2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS. Eur J Neurosci. 2005;21(3):658–68.
Machado I, Navarro S, Picci P, Llombart-Bosch A. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. Pathol Res Pract. 2016;212(9):811–6.
Szemes M, Gyorgy A, Paweletz C, Dobi A, Agoston DV. Isolation and characterization of SATB2, a novel AT-rich DNA binding protein expressed in development- and cell-specific manner in the rat brain. Neurochem Res. 2006;31(2):237–46.
Döcker D, Schubach M, Menzel M, Munz M, Spaich C, Biskup S, et al. Further delineation of the SATB2 phenotype. Eur J Hum Genet. 2014;22(8):1034–9.
Leoyklang P, Suphapeetiporn K, Siriwan P, Desudchit T, Chaowanapanja P, Gahl WA, et al. Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects. Hum Mutat. 2007;28(7):732–8.
Bengani H, Handley M, Alvi M, Ibitoye R, Lees M, Lynch SA, et al. Clinical and molecular consequences of disease-associated de novo mutations in SATB2. Genet Med. 2017;19(8):900–8.
Zarate YA, Kalsner L, Basinger A, Jones JR, Li C, Szybowska M, et al. Genotype and phenotype in 12 additional individuals with SATB2-associated syndrome. Clin Genet. 2017;92(4):423–9.
Lewis H, Samanta D, Örsell J-L, Bosanko KA, Rowell A, Jones M, et al. Epilepsy and electroencephalographic abnormalities in SATB2-associated syndrome. Pediatr Neurol. 2020;112:94–100.
Zarate YA, Bosanko KA, Caffrey AR, Bernstein JA, Martin DM, Williams MS, et al. Mutation update for the SATB2 gene. Hum Mutat. 2019;40(8):1013–29.
Zarate YA, Fish JL. SATB2-associated syndrome: mechanisms, phenotype, and practical recommendations. Am J Med Genet A. 2017;173(2):327–37.
Zarate YA, Smith-Hicks CL, Greene C, Abbott MA, Siu VM, Calhoun A, et al. Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome. Am J Med Genet A. 2018;176(4):925–35.
Zarate YA, Bosanko KA, Caffrey AR. SATB2-associated syndrome in adolescents and adults. Am J of Med Genet A. 2021;185(8):2391–8.
Thomason A, Pankey E, Nutt B, Caffrey AR, Zarate YA. Speech, language, and feeding phenotypes of SATB2-associated syndrome. Clin Genet. 2019;96(6):485–92.
Carrow-Woolfolk E. Test for auditory comprehension of language. 4th ed. Allen: Teaching Resources; 2014.
Zarate YA, Kaylor J, Fish J. SATB2-associated syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, et al., editors. GeneReviews. Seattle: University of Washington, Seattle; 2017.
Yamada M, Uehara T, Suzuki H, Takenouchi T, Yoshihashi H, Suzumura H, et al. SATB2-associated syndrome in patients from Japan: linguistic profiles. Am J Med Genet A. 2019;179(6):896–9.
Lee JS, Yoo Y, Lim BC, Kim KJ, Choi M, Chae JH. SATB2-associated syndrome presenting with Rett-like phenotypes. Clin Genet. 2016;89(6):728–32.
Balasubramanian M, Smith K, Basel-Vanagaite L, Feingold MF, Brock P, Gowans GC, et al. Case series: 2q33.1 microdeletion syndrome-further delineation of the phenotype. J Med Genet. 2011;48(5):290–8.
Clayton-Smith J, Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet. 2003;40(2):87–95.
Horsler K, Oliver C. The behavioural phenotype of Angelman syndrome. J Intellect Disabil Res. 2006;50(1):33–53.
Arron K, Oliver C, Moss J, Berg K, Burbidge C. The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res. 2011;55(2):109–20.
Trillingsgaard A, Østergaard JR. Autism in Angelman syndrome: an exploration of comorbidity. Autism. 2004;8(2):163–74.
Aguilera C, Gabau E, Ramirez-Mallafré A, Brun-Gasca C, Dominguez-Carral J, Delgadillo V, et al. New genes involved in Angelman syndrome-like: expanding the genetic spectrum. PLoS ONE. 2021;16(10):e0258766.
Loomes R, Hull L, Mandy WPL. What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(6):466–74.
Strang JF, van der Miesen AI, Caplan R, Hughes C, daVanport S, Lai M-C. Both sex- and gender-related factors should be considered in autism research and clinical practice. Autism. 2020;24(3):539–43.
Moss J, Howlin P. Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. J Intellect Disabil Res. 2009;53(10):852–73.
Richards C, Jones C, Groves L, Moss J, Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2015;2(10):909–16.
Cotton AP, Gokarakonda S, Caffrey AR, Zarate YA, Kumar N. Behavioral phenotype and sleep problems in SATB2-associated syndrome. Dev Med Child Neurol. 2020;62(7):827–32.
Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581–6.
Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry. 2001;40(11):1337–45.
GmbH L. LimeSurvey: an open source survey tool. Retrieved from: http://wwwlimesurveyorg. Germany: LimeSurvey GmbH, Hamburg, Germany; 2020.
Kushlick A, Blunden R, Cox G. A method of rating behaviour characteristies for use in large scale surveys of mental handicap. Psychol Med. 1973;3(4):466–78.
Oliver C, Royston R, Crawford H, Moss J, Waite J, Arron K. Informant assessments of behavior and affect for people with intellectual disability. Retrieved from: https://secureviewerzmagscom/publication/9964d37c. UK: University of Birmingham, Birmingham, UK; 2020.
Oliver C, Wilkie L. Gastro-oesophageal Distress Questionnaire. UK: University of Birmingham, Birmingham, UK; 2005.
Hall S, Arron K, Sloneem J, Oliver C. Health and sleep problems in Cornelia de Lange syndrome: a case control study. J Intellect Disabil Res. 2008;52(5):458–68.
Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism Screening Questionnaire: diagnostic validity. Br J Psychiatry. 1999;175:444–51.
Moss J, Oliver C. The Repetitive Behaviour Scale. Manual for administration and scorer interpretation. UK: University of Birmingham, Birmingham, UK; 2008.
Moss J, Oliver C, Arron K, Burbidge C, Berg K. The prevalence and phenomenology of repetitive behavior in genetic syndromes. J Autism Dev Disord. 2009;39(4):572–88.
Hyman P, Oliver C, Hall S. Self-injurious behavior, self-restraint, and compulsive behaviors in Cornelia de Lange syndrome. Am J Ment Retard. 2002;107(2):146–54.
Burbidge C, Oliver C. The Activity Questionnaire. Manual for administration and score interpretation. UK: University of Birmingham, Birmingham, UK; 2008.
Ross E, Arron K, Oliver C. The Mood Interest and Pleasure Questionnaire. Manual for administration and scoring. UK. Birmingham: University of Birmingham; 2008.
Esbensen AJ, Rojahn J, Aman MG, Ruedrich S. Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. J Autism Dev Disord. 2003;33(6):617–29.
Hermans H, Jelluma N, van der Pas FH, Evenhuis HM. Feasibility, reliability and validity of the Dutch translation of the Anxiety, Depression And Mood Scale in older adults with intellectual disabilities. Res Dev Disabil. 2012;33(2):315–23.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–70.
Adams D, Rose J, Jackson N, Karakatsani E, Oliver C. Coping strategies in mothers of children with intellectual disabilities showing multiple forms of challenging behaviour: associations with maternal mental health. Behav Cogn Psychother. 2018;46(3):257–75.
Hastings RP, Brown T. Behavior problems of children with autism, parental self-efficacy, and mental health. Am J Ment Retard. 2002;107(3):222–32.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.
Surtees AD, Richards C, Clarkson EL, Heald M, Trickett J, Denyer H, et al. Sleep problems in autism spectrum disorders: a comparison to sleep in typically developing children using actigraphy, diaries and questionnaires. Res Autism Spectr Disord. 2019;67:101439.
Jeffreys H. Theory of probability. 3rd ed. Oxford: University Press; 1961.
Steenfeldt-Kristensen C, Jones CA, Richards C. The prevalence of self-injurious behaviour in autism: a meta-analytic study. J Autism Dev Disord. 2020;50(11):3857–73.
Finucane B, Dirrigl KH, Simon EW. Characterization of self-injurious behaviors in children and adults with Smith-Magenis syndrome. Am J Ment Retard. 2001;106(1):52–8.
Oliver C, Murphy GH, Corbett J. Self-injurious behaviour in people with mental handicap: a total population study. J Intellect Disabil Res. 1987;31(2):147–62.
Borthwick-Duffy SA. Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol. 1994;62(1):17.
Crocker AG, Mercier C, Lachapelle Y, Brunet A, Morin D, Roy ME. Prevalence and types of aggressive behaviour among adults with intellectual disabilities. J Intellect Disabil Res. 2006;50(9):652–61.
Emerson E, Kiernan C, Alborz A, Reeves D, Mason H, Swarbrick R, et al. The prevalence of challenging behaviors: a total population study. Res Dev Disabil. 2001;22(1):77–93.
Oliver C, Berg K, Moss J, Arron K, Burbidge C. Delineation of behavioral phenotypes in genetic syndromes: characteristics of autism spectrum disorder, affect and hyperactivity. J Autism Dev Disord. 2011;41(8):1019–32.
Pelc K, Cheron G, Dan B. Behavior and neuropsychiatric manifestations in Angelman syndrome. Neuropsychiatr Dis Treat. 2008;4(3):577.
Chromik LC, Quintin E-M, Lepage J-F, Hustyi KM, Lightbody AA, Reiss AL. The influence of hyperactivity, impulsivity, and attention problems on social functioning in adolescents and young adults with fragile X syndrome. J Atten Disord. 2015;23(2):181–8.
Sullivan K, Hatton D, Hammer J, Sideris J, Hooper S, Ornstein P, et al. ADHD symptoms in children with FXS. Am J Med Genet A. 2006;140(21):2275–88.
Turk J. Fragile X syndrome: lifespan developmental implications for those without as well as with intellectual disability. Curr Opin Psychiatry. 2011;24(5):387–97.
Crawford H, Karakatsani E, Singla G, Oliver C. The persistence of self-injurious and aggressive behavior in males with fragile X syndrome over 8 years: a longitudinal study of prevalence and predictive risk markers. J Autism Dev Disord. 2019;49(7):2913–22.
Laverty C, Oliver C, Moss J, Nelson L, Richards C. Persistence and predictors of self-injurious behaviour in autism: a ten-year prospective cohort study. Mol Autism. 2020;11(1):8.
Cianfaglione R, Clarke A, Kerr M, Hastings RP, Oliver C, Felce D. Ageing in Rett syndrome. J Intellect Disabil Res. 2016;60(2):182–90.
Groves L, Moss J, Crawford H, Nelson L, Stinton C, Singla G, et al. Lifespan trajectory of affect in Cornelia de Lange syndrome: towards a neurobiological hypothesis. J Neurodev Disord. 2019;11(1):1–9.
Mingins JE, Tarver J, Waite J, Jones C, Surtees AD. Anxiety and intellectual functioning in autistic children: a systematic review and meta-analysis. Autism. 2021;25(1):18-32.
Berg K, Arron K, Burbidge C, Moss J, Oliver C. Carer-Reported contemporary health problems in people with severe and profound intellectual disability and genetic syndromes. J Policy Pract Intellect Disabil. 2007;4(2):120–8.
Hastings RP, Allen D, Baker P, Gore NJ, Hughes JC, McGill P, et al. A conceptual framework for understanding why challenging behaviours occur in people with developmental disabilities. Int J of Posit Behav Support. 2013;3(2):5–13.
McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027–35.
Mulder PA, Huisman S, Landlust AM, Moss J, Consortium SA, Piening S, et al. Development, behaviour and autism in individuals with SMC1A variants. J Child Psychol Psychiatry. 2019;60(3):305–13.
Lord C, Rutter M, DiLavore PC. Autism diagnostic observation schedule manual-2. 2nd ed. Los Angeles: Western Psychological Services; 2012.
Richards C, Powis L, Moss J, Stinton C, Nelson L, Oliver C. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder. J Neurodev Disord. 2017;9(1):37.
Kasari C, Gulsrud AC, Shire SY, Strawbridge C. The JASPER model for children with autism: promoting joint attention, symbolic play, engagement, and regulation. New York: Guilford Publications; 2021.
Crawford H, Moss J, Groves L, Dowlen R, Nelson L, Reid D, et al. A behavioural assessment of social anxiety and social motivation in Fragile X, Cornelia de Lange and Rubinstein-Taybi syndromes. J Autism Dev Disord. 2020;50(1):127–44.
Turner M. Annotation: Repetitive behaviour in autism: a review of psychological research. J Child Psychol Psychiatry. 1999;40(6):839–49.
Patterson SY, Smith V, Jelen M. Behavioural intervention practices for stereotypic and repetitive behaviour in individuals with autism spectrum disorder: a systematic review. Dev Med Child Neurol. 2010;52(4):318–27.
Jarosz AF, Wiley J. What are the odds? A practical guide to computing and reporting Bayes factors. J Probl Solving. 2014;7(1):2.
Charman T, Pickles A, Simonoff E, Chandler S, Loucas T, Baird G. IQ in children with autism spectrum disorders: data from the Special Needs and Autism Project (SNAP). Psychol Med. 2011;41(3):619–27.
Postorino V, Fatta LM, Sanges V, Giovagnoli G, De Peppo L, Vicari S, et al. Intellectual disability in autism spectrum disorder: investigation of prevalence in an Italian sample of children and adolescents. Res Dev Disabil. 2016;48:193–201.
Haney JL. Autism, females, and the DSM-5: Gender bias in autism diagnosis. Soc Work Ment Health. 2016;14(4):396–407.
Zarate YA, Bosanko KA, Thomas MA, Miller DT, Cusmano-Ozog K, Martinez-Monseny A, et al. Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2. Clin Genet. 2021;99(4):547-557.
van Ool JS, Snoeijen-Schouwenaars FM, Tan IY, Jurgen Schelhaas H, Aldenkamp AP, Hendriksen JGM. Challenging behavior in adults with epilepsy and intellectual disability: an analysis of epilepsy characteristics. Epilepsy Behav. 2018;86:72–8.
Sigafoos J. Communication development and aberrant behavior in children with developmental disabilities. Educ Train Autism Dev Disabil. 2000;35(2):168–76.
The authors would particularly like to thank Allison Kaczenski and Maria Walters for all of their efforts with international recruitment and for their continued support of this study. We are extremely grateful to all families who participated in this research.
This study was funded by Cerebra. Cerebra were not involved in the design, recruitment, analysis, or data interpretation of this individual study but provide ongoing core research funding to the study authors.
Ethics approval and consent to participate
Ethical approval was obtained for this study in 2010 from Coventry Research Ethics Committee, as part of a larger ongoing study entitled ‘Understanding behaviour and family adjustment in individuals with neurodevelopmental disorders’ (REC Reference Number: 10/H1210/01).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Group characteristics and associated comparative analyses for 18 participants in SAS group who could not be matched for inclusion in cross-syndrome analyses. Post hoc cross-syndrome statistics for AS-autism comparisons. Item-level post hoc comparisons across individual SCQ items (excluding participants under 4 years).
About this article
Cite this article
Bissell, S., Oliver, C., Moss, J. et al. The behavioural phenotype of SATB2-associated syndrome: a within-group and cross-syndrome analysis. J Neurodevelop Disord 14, 25 (2022). https://doi.org/10.1186/s11689-022-09426-0
- Behavioural phenotype
- SATB2-associated syndrome
- Angelman syndrome
- Challenging behaviour
- Repetitive behaviour
- Stereotyped behaviour
- Compulsive behaviour
- Emotional characteristics